Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain.

Weekman EM, Woolums AE, Sudduth TL, Wilcock DM.

ASN Neuro. 2017 Nov-Dec;9(6):1759091417742296. doi: 10.1177/1759091417742296.

2.

Neuroinflammation induced by amyloid β25-35 modifies mucin-type O-glycosylation in the rat's hippocampus.

Ramos-Martinez I, Martínez-Loustalot P, Lozano L, Issad T, Limón D, Díaz A, Perez-Torres A, Guevara J, Zenteno E.

Neuropeptides. 2018 Feb;67:56-62. doi: 10.1016/j.npep.2017.11.008. Epub 2017 Nov 21.

PMID:
29174415
3.

An amylin analog used as a challenge test for Alzheimer's disease.

Zhu H, Stern RA, Tao Q, Bourlas A, Essis MD, Chivukula M, Rosenzweig J, Steenkamp D, Xia W, Mercier GA, Tripodis Y, Farlow M, Kowall N, Qiu WQ.

Alzheimers Dement (N Y). 2017 Jan;3(1):33-43. doi: 10.1016/j.trci.2016.12.002.

4.

Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease.

Zou C, Shi Y, Ohli J, Schüller U, Dorostkar MM, Herms J.

Acta Neuropathol. 2016 Feb;131(2):235-246. doi: 10.1007/s00401-015-1527-8. Epub 2016 Jan 2.

5.

Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.

Roerink ME, Groen RJ, Franssen G, Lemmers-van de Weem B, Boerman OC, van der Meer JW.

Alzheimers Res Ther. 2015 Nov 12;7(1):70. doi: 10.1186/s13195-015-0149-7.

6.

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K.

Brain. 2015 Jun;138(Pt 6):1738-55. doi: 10.1093/brain/awv081. Epub 2015 Mar 31.

7.

Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.

Gonçalves NP, Vieira P, Saraiva MJ.

Amyloid. 2014 Sep;21(3):175-84. doi: 10.3109/13506129.2014.927759. Epub 2014 Jun 11.

8.

[Inflammatory markers in schizophrenia in aged].

Androsova LV, Mikhaĭlova NM, Zozulia SA, Dupin AM, Kliushnik TP.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(12):60-64. doi: 10.17116/jnevro201411412160-64. Russian.

PMID:
25726782
9.

Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an Alzheimer's disease model.

Ben-Menachem-Zidon O, Ben-Menahem Y, Ben-Hur T, Yirmiya R.

Neuropsychopharmacology. 2014 Jan;39(2):401-14. doi: 10.1038/npp.2013.208. Epub 2013 Aug 19. Erratum in: Neuropsychopharmacology. 2015 Jan;40(2):524. Neuropsychopharmacology. 2013 Dec;38(13):2736. Ben Menachem-Zidon, Ofra [corrected to Ben-Menachem-Zidon, Ofra].

10.

Silencing of the P2X(7) receptor enhances amyloid-β phagocytosis by microglia.

Ni J, Wang P, Zhang J, Chen W, Gu L.

Biochem Biophys Res Commun. 2013 May 3;434(2):363-9. doi: 10.1016/j.bbrc.2013.03.079. Epub 2013 Apr 4.

PMID:
23562658
11.

Gossypium herbaceam L. extracts ameliorate disequilibrium of IL-1RA/IL-1β ratio to attenuate inflammatory process induced by amyloid β in rats.

Ji C, Song C, Aisa HA, Yang N, Liu YY, Li Q, Zhu HB, Zuo PP.

Curr Alzheimer Res. 2012 Oct;9(8):953-61.

PMID:
22950889
12.

Association of interleukin 1β polymorphisms and haplotypes with Alzheimer's disease.

Payão SL, Gonçalves GM, de Labio RW, Horiguchi L, Mizumoto I, Rasmussen LT, de Souza Pinhel MA, Silva Souza DR, Bechara MD, Chen E, Mazzotti DR, Ferreira Bertolucci PH, Cardoso Smith Mde A.

J Neuroimmunol. 2012 Jun 15;247(1-2):59-62. doi: 10.1016/j.jneuroim.2012.03.012. Epub 2012 Apr 10.

13.

CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.

Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C.

J Neurosci. 2011 Nov 9;31(45):16241-50. doi: 10.1523/JNEUROSCI.3667-11.2011.

14.

The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Benke KS, Carlson MC, Doan BQ, Walston JD, Xue QL, Reiner AP, Fried LP, Arking DE, Chakravarti A, Fallin MD.

Exp Gerontol. 2011 Dec;46(12):1010-9. doi: 10.1016/j.exger.2011.09.005. Epub 2011 Sep 24.

16.

The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.

Schmid AW, Lynch MA, Herron CE.

Hippocampus. 2009 Jul;19(7):670-6. doi: 10.1002/hipo.20542.

PMID:
19115392
17.

Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist.

Oprica M, Hjorth E, Spulber S, Popescu BO, Ankarcrona M, Winblad B, Schultzberg M.

J Cell Mol Med. 2007 Jul-Aug;11(4):810-25.

18.

Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.

Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S.

Neurology. 2007 May 29;68(22):1902-8.

PMID:
17536046
19.

IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Marcos-Carcavilla A, Calvo JH, González C, Moazami-Goudarzi K, Laurent P, Bertaud M, Hayes H, Beattie AE, Serrano C, Lyahyai J, Martín-Burriel I, Alves E, Zaragoza P, Badiola JJ, Serrano M.

Mamm Genome. 2007 Jan;18(1):53-63. Epub 2007 Jan 22.

PMID:
17242860
20.

Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid.

Même W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, Giaume C.

FASEB J. 2006 Mar;20(3):494-6. Epub 2006 Jan 19.

PMID:
16423877

Supplemental Content

Loading ...
Support Center